KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oracle (ORCL) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Oracle (ORCL) over the last 17 years, with Nov 2025 value amounting to -$1.0 billion.

  • Oracle's Change in Accured Expenses fell 68.63% to -$1.0 billion in Q4 2025 from the same period last year, while for Nov 2025 it was -$831.0 million, marking a year-over-year decrease of 20.61%. This contributed to the annual value of -$608.0 million for FY2025, which is 2.36% down from last year.
  • Oracle's Change in Accured Expenses amounted to -$1.0 billion in Q4 2025, which was down 208.98% from -$334.0 million recorded in Q3 2025.
  • Oracle's 5-year Change in Accured Expenses high stood at $510.0 million for Q1 2025, and its period low was -$1.0 billion during Q4 2025.
  • In the last 3 years, Oracle's Change in Accured Expenses had a median value of -$166.0 million in 2023 and averaged -$172.0 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 545.65% in 2021, then surged by 23,400.00% in 2022.
  • Over the past 5 years, Oracle's Change in Accured Expenses (Quarterly) stood at -$205.0 million in 2021, then plummeted by 201.95% to -$619.0 million in 2022, then climbed by 4.52% to -$591.0 million in 2023, then dropped by 3.55% to -$612.0 million in 2024, then plummeted by 68.63% to -$1.0 billion in 2025.
  • Its Change in Accured Expenses was -$1.0 billion in Q4 2025, compared to -$334.0 million in Q3 2025 and $25.0 million in Q2 2025.